InsidersTradesSigma
Kintor Pharmaceutical Ltd. - B: management transactions · Hong Kong · HKEX
HKEX:kintor-pharmaceutical-ltd-bHK·HKEXMcap 919M€Healthcare
Browse the full insider trade history of Kintor Pharmaceutical Ltd. - B, a publicly traded company based in Hong Kong. Shares trade on HK HK, under the authority of HKEX. Operating in the Healthcare sector, Kintor Pharmaceutical Ltd. - B has published 10 insider filings. Market capitalisation: €919.1m. The latest transaction was filed on 11 May 2026 — Purchase. Among the most active insiders: Tong Youzhi. Every trade is free.
10
Insider Decl.
0
Thresholds
€191,011
8 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2.79 €
Income statement
Revenue32.7 M€
Gross profit8.0 M€25% margin
Net income−200.1 M€-612.3% margin
Balance sheet & cash
Market cap919.1 M€
Total debt86.6 M€
Free Cash Flow−170.5 M€
Last declaration on 11 May 2026
Declarations10 total
Executives●Purchase3HKEX
€24,98280,000 shares@ €0.31230.0027% mcap13.1% of flow
ShareXHKG
HKEX:DA20260511E00237·
Ideal exit: 2 Feb 2027 (T+270)
Executives●Purchase2HKEX
€8,06528,000 shares@ €0.2880.0009% mcap4.2% of flow
ShareXHKG
HKEX:DA20260427E00032·
Ideal exit: 19 Jan 2027 (T+270)
Executives●Purchase3HKEX
€14,18648,000 shares@ €0.29550.0015% mcap7.4% of flow
ShareXHKG
HKEX:DA20260422E00263·
Ideal exit: 16 Jan 2027 (T+270)
Executives●Purchase2HKEX
€2,98010,000 shares@ €0.2980.0003% mcap1.6% of flow
ShareXHKG
HKEX:DA20260420E00094·
Ideal exit: 12 Jan 2027 (T+270)
Executives●Purchase8HKEX
€86,666290,000 shares@ €0.29880.0094% mcap45.4% of flow
ShareXHKG
HKEX:DA20260417E00334·
Ideal exit: 11 Jan 2027 (T+270)
Executives●Purchase3HKEX
€14,41250,000 shares@ €0.28820.0016% mcap7.5% of flow
ShareXHKG
HKEX:DA20260410E00214·
Ideal exit: 4 Jan 2027 (T+270)
Executives●Purchase3HKEX
€19,21765,000 shares@ €0.29560.0021% mcap10.1% of flow
ShareXHKG
HKEX:DA20260409E00109·
Ideal exit: 3 Jan 2027 (T+270)
Executives●Purchase3HKEX
€20,50371,500 shares@ €0.28680.0022% mcap10.7% of flow
ShareXHKG
HKEX:DA20260407E00049·
Ideal exit: 28 Dec 2026 (T+270)
10 of 10 declarations